Modalităţi evolutive particulare în infecţia SARS-CoV-2

Modalităţi evolutive particulare în infecţia SARS-CoV-2

Pandemia COVID-19 a pus lumea medicală în faţa multor provocări privind diagnosticul şi opţiunile terapeutice. Prezentăm trei cazuri de pacienţi proveniţi din grupe de vârstă diferite, la care am identificat modalităţi evolutive particulare, din punct de vedere clinic şi al investigaţiilor de labora...

Full description

Bibliographic Details
Main Authors:	Ştefan Lazăr, Adela Neculai, Loredana Muşetescu, Carmen Marcu, Simina Dinu, Maria Nica, Emanoil Ceauşu, Simin-Aysel Florescu
Format:	Article
Language:	English
Published:	Amaltea Medical Publishing House 2020-06-01
Series:	Romanian Journal of Infectious Diseases
Subjects:	sars-cov-2 covid-19 calculator de risc la admisia în spital tocilizumab rt-pcr sars-cov-2 policitemie
Online Access:	https://rjid.com.ro/articles/2020.2/RJID_2020_2_RO_Art-18.pdf

Similar Items

Particular evolutive modalities in SARS-CoV-2 infection
by: Stefan Lazar, et al.
Published: (2020-06-01)

Caracteristici epidemiologice principale ale cazurilor de COVID-19 internate în spital din prima linie de apărare din Bucureşti, România
by: Niculae Ion Nedelcu, et al.
Published: (2020-09-01)

Anosmia – an independent predictor in the persistence of SARS-CoV-2 infection?
by: Stefan Lazar, et al.
Published: (2020-06-01)

Anosmia – predictor independent în persistenţa infecţiei SARS-CoV-2?
by: Ştefan Lazăr, et al.
Published: (2020-06-01)

The Role for Tocilizumab in COVID-19 Patients: Reflections on Monza Cohort Data
by: Capici S, et al.
Published: (2021-04-01)

A PARTICULAR CASE OF SARS-COV-2 INFECTION IN TWINS
by: Andreea Florentina Stoenescu, et al.
Published: (2021-06-01)

Radiological aspects in patients diagnosed with SARS-CoV-2 infection – a literature review
by: Maria Cristina Hoara, et al.
Published: (2020-06-01)

The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review
by: Avi Gurion Kaye, et al.
Published: (2020-11-01)

Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 Treated with Tocilizumab
by: Carmen Niño-Taravilla, et al.
Published: (2020-12-01)

The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response
by: Seniha Başaran, et al.
Published: (2021-04-01)

A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital
by: Salma AlBahrani, et al.
Published: (2021-01-01)

Aspecte radiologice la pacienţii diagnosticaţi cu infecţie cu SARS-CoV-2 – un review de literatură
by: Maria Cristina Hoară, et al.
Published: (2020-06-01)

Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study
by: Zarębska-Michaluk D, et al.
Published: (2021-07-01)

Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study
by: Jing Zhang, et al.
Published: (2020-10-01)

Compassionate use of tocilizumab in severe SARS-CoV2 pneumonia
by: Miguel Górgolas Hernández-Mora, et al.
Published: (2021-01-01)

Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review
by: A. Cortegiani, et al.
Published: (2021-01-01)

Matched cohort study on the efficacy of tocilizumab in patients with COVID-19
by: Alejandro Rodríguez-Molinero, et al.
Published: (2021-06-01)

Multimodality treatment in immunocompromised patients with severe COVID‐19: the role of IL‐6 inhibitor, intravenous immunoglobulin, and haemoperfusion
by: Nophol Leelayuwatanakul, et al.
Published: (2021-04-01)

Efficacy of tocilizumab treatment in COVID-19 patients with cytokine release syndrome
by: Hayat Kumbasar, et al.
Published: (2021-03-01)

Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era
by: Cori Campbell, et al.
Published: (2021-08-01)

First Report of Tocilizumab Use in a Cohort of Latin American Patients Hospitalized for Severe COVID-19 Pneumonia
by: Omar Valenzuela, et al.
Published: (2020-11-01)

Anti-IL6R role in treatment of COVID-19-related ARDS
by: Franco Maria Buonaguro, et al.
Published: (2020-04-01)

Battling COVID-19: using old weapons for a new enemy
by: Rohit Kumar, et al.
Published: (2020-05-01)

Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
by: Koichiro Yamamoto, et al.
Published: (2021-09-01)

Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study
by: Erica Franceschini, et al.
Published: (2021-09-01)

Therapeutic potential of anticoagulant therapy in association with cytokine storm inhibition in severe cases of COVID-19: A case report
by: Xu Qiancheng, et al.
Published: (2021-08-01)

Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6
by: Robert Flisiak, et al.
Published: (2021-04-01)

Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size
by: Hong Zhao, et al.
Published: (2021-01-01)

Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
by: Corrado Pelaia, et al.
Published: (2021-03-01)

Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study
by: Francisco López-Medrano, et al.
Published: (2021-04-01)

Main epidemiological features of COVID-19 cases admitted in a first line defence hospital from Bucharest, Romania
by: Niculae Ion Nedelcu, et al.
Published: (2020-09-01)

Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness
by: John A. Lednicky, et al.
Published: (2021-07-01)

Tocilizumab as a Treatment for ‘Cytokine Storm Syndrome’ in COVID-19: A Case Report
by: Ari Fahrial Syam, et al.
Published: (2021-07-01)

Case Report: Tocilizumab for the Treatment of SARS-CoV-2 Infection in a Patient With Aplastic Anemia
by: Gina Keiffer, et al.
Published: (2020-09-01)

Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid
by: Antonio Calles, et al.
Published: (2020-09-01)

Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients
by: Timothée Klopfenstein, et al.
Published: (2020-10-01)

How to follow-up a patient who received tocilizumab in severe COVID-19: a case report
by: Regina B. Podlasin, et al.
Published: (2020-08-01)

Temporal Clinical and Laboratory Response to Interleukin-6 Receptor Blockade With Tocilizumab in 89 Hospitalized Patients With COVID-19 Pneumonia
by: Daria Fomina, et al.
Published: (2020-10-01)

IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections
by: Lucas M. Kimmig, et al.
Published: (2020-10-01)

COVID-19 and Pulmonary Embolism: Not a Coincidence
by: Adriana Tamburello, et al.
Published: (2020-05-01)